Sign In
Buy VCEL
$45.96
-1.65 (-3.47%)
At Close: Jul 31, 2026
Vericel Q2 Earnings Call Highlights
05:04pm, Thursday, 30'th Jul 2026
Vericel NASDAQ: VCEL reported record second-quarter revenue and raised its full-year outlook, citing continued growth in its MACI cartilage repair franchise and Burn Care business, along with improved
Vericel Corporation (VCEL) Q2 2026 Earnings Call Transcript
12:54pm, Thursday, 30'th Jul 2026
Vericel Corporation (VCEL) Q2 2026 Earnings Call Transcript
Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates
10:36am, Thursday, 30'th Jul 2026
Vericel Corporation (VCEL) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to a loss of $0.01 per share a year ago
Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
07:55am, Thursday, 30'th Jul 2026
Total Revenue Increased 22% to $77.5 Million, with MACI Revenue Growth of 23% Net Income of $2.2 Million and Free Cash Flow of $14.3 Million Full-Year 2026 Revenue Guidance Raised to $330 to $340 Mill
Vericel Corporation $VCEL Shares Sold by Allspring Global Investments Holdings LLC
03:08am, Tuesday, 21'st Jul 2026
Allspring Global Investments Holdings LLC trimmed its position in Vericel Corporation (NASDAQ: VCEL) by 3.1% during the first quarter, according to its most recent filing with the Securities and Excha
Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026
08:30am, Thursday, 16'th Jul 2026
BURLINGTON, Mass., July 16, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Co
Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests
12:58pm, Saturday, 27'th Jun 2026
10,000 Common Stock shares were sold for a transaction value of $402,000 at an average price of around $40.24 per share on June 18, 2026. The sale represented 38% of Halpin's direct Common Stock holdi
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
08:30am, Tuesday, 09'th Jun 2026
BURLINGTON, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Co
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
02:39pm, Saturday, 30'th May 2026
Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States.
Vericel Q1 Earnings Call Highlights
02:10am, Saturday, 09'th May 2026
Vericel NASDAQ: VCEL reported record first-quarter revenue and raised its full-year 2026 outlook, citing strong growth across its MACI cartilage repair franchise and Burn Care business, as well as exp
Vericel Corporation (VCEL) Q1 2026 Earnings Call Transcript
11:31pm, Thursday, 07'th May 2026
Vericel Corporation (VCEL) Q1 2026 Earnings Call Transcript
Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates
12:16pm, Thursday, 07'th May 2026
Vericel Corporation (VCEL) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.23 per share a year ago.
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
07:45am, Thursday, 07'th May 2026
Total Revenue Increased 30% to $68.4 Million, with MACI Revenue Growth of 22% and Burn Care Revenue Growth of 91%
Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet
10:56am, Monday, 04'th May 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 53.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positi
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
08:30am, Thursday, 23'rd Apr 2026
CAMBRIDGE, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Co
